The enormous volume of cancer work has revealed much for the field of tuberculosis; checkpoint inhibition through a combination of PD-1 and TIM3 may be required for the successful reversal of T cell exhaustion, and macrophage polarization immunotherapies have been successfully used to modulate the immune response. The gene discussed is HAVCR2; the disease is cancer.